Gilead and Merck initiate phase-II study on Lenacapavir and Islatravir oral combo for HIV-1 treatment in virologically suppressed adults Read more
Kite and Shoreline Biosciences enter partnership to develop novel allogeneic cell therapies Read more
Drug makers, BMGF pledge to strive for global access to COVID-19 diagnostics, therapeutics and vaccines Read more
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines: GlobalData Read more